A Novel Immune-Prognosis Index Predicts the Benefit of Lung Adenocarcinoma Patients

• Päätekijät: Yuquan Bai (Tekijä), Yun Pei (Tekijä), Liang Xia (Tekijä), Lin Ma (Tekijä), Senyi Deng (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Frontiers Media S.A., 2022-05-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Background: Constructed an immune-prognosis index (IPI) and divided lung adenocarcinoma (LUAD) patients into different subgroups according to IPI score, describe the molecular and immune characteristics of patients between different IPI subgroups, and explore their response to immune checkpoint bloc...